Health care stocks were flat to lower premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.4% and the iShares Biotechnology ETF (IBB) was recently inactive.
BrightSpring Health Services (BTSG) shares advanced by 5% after the company reported higher Q4 adjusted earnings and revenue. The company also raised its 2025 revenue outlook.
Aquestive Therapeutics (AQST) shares were down nearly 7% after the company reported a wider Q4 net loss as revenue fell during the period.
QIAGEN (QGEN) shares were up nearly 2% after the company said the US Food and Drug Administration has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, marking the company's second FDA clearance of a QIAstat-Dx panel in 2025.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。